{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:45:41Z","timestamp":1787237141969,"version":"build-2736575974"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T00:00:00Z","timestamp":1770076800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100020367","name":"Louisiana Cancer Research Consortium, Xavier University of Louisiana","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020367","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>ERCC6, also known as CSB (Cockayne Syndrome B), is a key protein involved in transcription-coupled nucleotide excision repair (TC-NER), a DNA repair process that removes lesions blocking RNA polymerase. ERCC6\u2019s multifaceted roles include chromatin remodeling, transcription regulation, oxidative stress response, and coordination with other DNA repair proteins. Mutations in ERCC6 lead to Cockayne Syndrome and other neurodegenerative disorders, but some variants, such as M1097V, have been associated with cancer risk, particularly prostate cancer (PCa) in African Americans (AAs) in Louisiana. Recent studies have explored the functional impact of ERCC6 variants in PCa, especially among AAs, who face higher incidence and more aggressive forms of the disease. A notable finding is that the M1097V variant increases cellular tolerance to UV damage, suggesting not only a possible evolutionary benefit but also a potential risk for mutagenesis when exposed to complex environmental carcinogens. Other ERCC6 mutations, such as S636N (also only found in Louisiana PCa), located near regulatory regions, may alter repair activity, though their effects remain unclear. Given the high mutation burden in mismatch repair (MMR) and NER genes observed in AA patients with PCa, a synthetic lethality strategy targeting both TC-NER and homologous recombination repair (HRR) pathways could be effective. This includes combining agents like CDDP (cisplatin) with inhibitors of RAD54, such as J54. These approaches may offer alternatives to androgen deprivation therapy (ADT), which is often ineffective in advanced or treatment-resistant PCa common among AA men. This work underscores the importance of integrating genetic, environmental, and therapeutic insights to address PCa disparities.<\/jats:p>","DOI":"10.3389\/fonc.2025.1679379","type":"journal-article","created":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T05:21:45Z","timestamp":1770096105000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Studies on the functionality of the TC-NER ERCC6-M1097V protein variant frequently found in Louisiana patients with PCa upon UV damage"],"prefix":"10.3389","volume":"15","author":[{"given":"Oluwatobi","family":"Ogundepo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arrigo","family":"De Benedetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,2,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1093\/plcell\/koae052","article-title":"The chromatin remodeler ERCC6 and the histone chaperone NAP1 are involved in apurinic\/apyrimidinic endonuclease-mediated DNA repair","volume":"36","author":"Fan","year":"2024","journal-title":"Plant Cell"},{"key":"B2","doi-asserted-by":"publisher","first-page":"866","DOI":"10.3390\/cells10040866","article-title":"Cockayne syndrome group B (CSB): the regulatory framework governing the multifunctional protein and its plausible role in cancer","volume":"10","author":"Spyropoulou","year":"2021","journal-title":"Cells"},{"key":"B3","doi-asserted-by":"publisher","first-page":"2656","DOI":"10.3390\/cancers13112656","article-title":"Race as a contributor to stromal modulation of tumor progression","volume":"13","author":"Kakarla","year":"2021","journal-title":"Cancers"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111771","article-title":"Identification of DNA damage repair-Associated prognostic biomarkers for prostate cancer using transcriptomic data analysis","volume":"22","author":"Teng","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","first-page":"e2021692","DOI":"10.1001\/jamanetworkopen.2020.21692","article-title":"activity of platinum-based chemotherapy in patients with advanced prostate cancer with and without DNA repair gene aberrations","volume":"3","author":"Schmid","year":"2020","journal-title":"JAMA network Open"},{"key":"B6","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41391-019-0153-2","article-title":"Role of the DNA damage response in prostate cancer formation, progression and treatment","volume":"23","author":"Zhang","year":"2020","journal-title":"Prostate Cancer prostatic Dis"},{"key":"B7","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.currproblcancer.2017.06.001","article-title":"Relevance of DNA damage repair in the management of prostate cancer","volume":"41","author":"Banks","year":"2017","journal-title":"Curr problems Cancer"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1911440","article-title":"olaparib for metastatic castration-resistant prostate cancer","volume":"382","author":"de Bono","year":"2020","journal-title":"New Engl J Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-20-0394","article-title":"non-BRCA DNA damage repair gene alterations and response to the PARP inhibitor rucaparib in metastatic castration-resistant prostate cancer: analysis from the phase II TRITON2 study","volume":"26","author":"Abida","year":"2020","journal-title":"Clin Cancer Res"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1406","DOI":"10.3390\/biomedicines9101406","article-title":"Cisplatin mouse models: treatment, toxicity and translatability","volume":"9","author":"Per\u0161e","year":"2021","journal-title":"Biomedicines"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1038\/s41388-020-1280-x","article-title":"Somatic mutations in the DNA repairome in prostate cancers in African Americans and Caucasians","volume":"39","author":"Yadav","year":"2020","journal-title":"Oncogene"},{"key":"B12","article-title":"Significant association of ERCC6 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan","volume":"29","author":"Chang","year":"2009","journal-title":"Anticancer Res"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1002\/humu.24220","article-title":"Genetic pleiotropy of ERCC6 loss-of-function and deleterious missense variants links retinal dystrophy, arrhythmia, and immunodeficiency in diverse ancestries","volume":"42","author":"Forrest","year":"2021","journal-title":"Hum Mutat"},{"key":"B14","doi-asserted-by":"publisher","first-page":"2662666","DOI":"10.1155\/2022\/2662666","article-title":"Genetic association of ERCC6 rs2228526 polymorphism with the risk of cancer: evidence from a meta-analysis","volume":"2022","author":"Lin","year":"2022","journal-title":"BioMed Res Int"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1158\/1055-9965.EPI-10-0684","article-title":"Obesity and prostate cancer aggressiveness among African and Caucasian Americans in a population-based study","volume":"20","author":"Su","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"B16","volume-title":"Welcome to \u201cCancer Alley\u201d where toxic air is about to get worse","author":"Baurick","year":"2019"},{"key":"B17","volume-title":"NEK1 Phosphorylation Modulates ERCC6 in Transcription-Coupled Nucleotide Excision Repair","author":"Ogundepo","year":"2025"},{"key":"B18","doi-asserted-by":"publisher","first-page":"3666","DOI":"10.3390\/cancers12123666","article-title":"NEK1 phosphorylation of YAP promotes its stabilization and transcriptional output","volume":"12","author":"Khalil","year":"2020","journal-title":"Cancers"},{"key":"B19","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s12953-015-0065-6","article-title":"New interaction partners for Nek4.1 and Nek4.2 isoforms: from the DNA damage response to RNA splicing","volume":"13","author":"Basei","year":"2015","journal-title":"Proteome Sci"},{"key":"B20","doi-asserted-by":"publisher","first-page":"103161","DOI":"10.1016\/j.dnarep.2021.103161","article-title":"Strand discrimination in DNA mismatch repair","volume":"105","author":"Putnam","year":"2021","journal-title":"DNA Repair (Amst)"},{"key":"B21","doi-asserted-by":"publisher","first-page":"2987","DOI":"10.3390\/biomedicines11112987","article-title":"Exploiting TLK1 and cisplatin synergy for synthetic lethality in androgen-insensitive prostate cancer","volume":"11","author":"Bhoir","year":"2023","journal-title":"Biomedicines"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2005.09.022","article-title":"Recognition of RNA polymerase II and transcription bubbles by XPG, CSB, and TFIIH: insights for transcription-coupled repair and Cockayne Syndrome","volume":"20","author":"Sarker","year":"2005","journal-title":"Mol Cell"},{"key":"B23","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkad589","article-title":"TLK1-mediated RAD54 phosphorylation spatio-temporally regulates Homologous Recombination Repair","volume":"51","author":"Ghosh","year":"2023","journal-title":"Nucleic Acids Res."},{"key":"B24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/s41467-017-02497-x","article-title":"RAD54 N-terminal domain is a DNA sensor that couples ATP hydrolysis with branch migration of Holliday junctions","volume":"9","author":"Goyal","year":"2018","journal-title":"Nat Commun"},{"key":"B25","doi-asserted-by":"publisher","first-page":"416","DOI":"10.3390\/curroncol32080416","article-title":"Mediation analysis to investigate differences in prostate cancer diagnosis stage through environmental risk factors in Louisiana","volume":"32","author":"Rizvi","year":"2025","journal-title":"Curr Oncol"},{"key":"B26","article-title":"A mutator phenotype in cancer","volume":"61","author":"Loeb","year":"2001","journal-title":"Cancer Res"},{"key":"B27","doi-asserted-by":"publisher","first-page":"101474","DOI":"10.1016\/j.isci.2020.101474","article-title":"Generation of phenothiazine with potent anti-TLK1 activity for prostate cancer therapy","volume":"23","author":"Singh","year":"2020","journal-title":"Iscience"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.32200","article-title":"Targeting the TLK1\/NEK1 DDR axis with Thioridazine suppresses outgrowth of androgen independent prostate tumors","volume":"145","author":"Singh","year":"2019","journal-title":"Int J Cancer"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2019.03.041","article-title":"The TLK1-Nek1 axis promotes prostate cancer progression","volume":"453","author":"Singh","year":"2019","journal-title":"Cancer Lett"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.5534\/wjmh.210070","article-title":"Racial differences in prostate cancer characteristics and cancer-specific mortality: an overview","volume":"40","author":"Hinata","year":"2022","journal-title":"World J Mens Health"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.clgc.2023.04.008","article-title":"Outcomes of second-Line therapies in patients with metastatic de novo and treatment-Emergent neuroendocrine prostate cancer: A multi-Institutional study","volume":"21","author":"Eule","year":"2023","journal-title":"Clin Genitourin Cancer"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1002\/advs.202500632","article-title":"A dual approach with organoid and CRISPR screening reveals ERCC6 as a determinant of cisplatin resistance in osteosarcoma","volume":"12","author":"Xu","year":"2025","journal-title":"Adv Sci (Weinh)"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(19)30408-5","article-title":"Cabazitaxel plus carboplatin for the treatment of men with metastatic castration-resistant prostate cancers: a randomised, open-label, phase 1\u20132 trial","volume":"20","author":"Corn","year":"2019","journal-title":"Lancet Oncol"},{"key":"B34","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1038\/s41419-020-02970-4","article-title":"Preclinical studies using cisplatin\/carboplatin to restore the Enzalutamide sensitivity via degrading the androgen receptor splicing variant 7 (ARv7) to further suppress Enzalutamide resistant prostate cancer","volume":"11","author":"Chou","year":"2020","journal-title":"Cell Death Dis"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.62117","article-title":"Structural basis for transcription complex disruption by the Mfd translocase","volume":"10","author":"Kang","year":"2021","journal-title":"eLife"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1679379\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,3]],"date-time":"2026-02-03T05:21:47Z","timestamp":1770096107000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1679379\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,3]]},"references-count":35,"alternative-id":["10.3389\/fonc.2025.1679379"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1679379","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,3]]},"article-number":"1679379"}}